FAWN
发表于 2025-3-28 14:47:02
http://reply.papertrans.cn/47/4648/464725/464725_41.png
CROAK
发表于 2025-3-28 19:14:33
Emerging Roles of Endothelial Cells in Multiple Sclerosis Pathophysiology and Therapy,veral types of intercellular junctions which isolate the circulation from the brain as the functional neuro- and gliovascular units of the BBB. In health, the BBB generally isolates the brain parenchyma from immune cells and blood-borne neurotransmitters (glutamate, norepinephrine, serotonin) contro
patella
发表于 2025-3-28 22:56:43
Multiple Sclerosis: Clinical Features, Immunopathogenesis, and Treatment,oxysmal manifestations. These symptoms necessitate a myriad of treatment approaches tailored to individual patient needs. A boom in the development of disease-modifying therapies for MS has resulted in 14 currently FDA-approved medications for relapsing-remitting MS in 2016 compared to just a handfu
Alcove
发表于 2025-3-29 05:35:14
http://reply.papertrans.cn/47/4648/464725/464725_44.png
Ischemic-Stroke
发表于 2025-3-29 11:01:19
Neurosarcoidosis: Clinical Features, Pathogenesis, and Management,ly, the treatment is based on chronic immunosuppression utilizing TNF-α antagonists, corticosteroids, and a number of cytotoxic medications. Symptomatic treatments of the neurologic complications of neurosarcoidosis involve multiple treatment teams and use of various medications.
CRUC
发表于 2025-3-29 13:22:10
Immunopathogenesis and Treatment of Guillain-Barre Syndrome and Chronic Inflammatory Demyelinatingthere are relapses. On the other hand, maintenance treatment with the aforementioned treatment modalities, as well as corticosteroids or other immunosuppressants, is frequently needed in CIDP patients. Further advances in the understanding of immunopathogenesis of these diseases will likely result
钢笔尖
发表于 2025-3-29 17:23:27
http://reply.papertrans.cn/47/4648/464725/464725_47.png
羽毛长成
发表于 2025-3-29 21:43:17
http://reply.papertrans.cn/47/4648/464725/464725_48.png
Host142
发表于 2025-3-29 23:53:43
http://reply.papertrans.cn/47/4648/464725/464725_49.png
灿烂
发表于 2025-3-30 06:55:18
Central Nervous System Vasculitis: Immunopathogenesis, Clinical Aspects, and Treatment Options,nt immunosuppressive therapy, as well as the choice and dosing of therapy, along with the duration, are important determinants of outcome in central nervous vasculitis. We hope to provide updated information toward these goals in this chapter.